Class information for:
Level 1: 3 4 DIHYDROXYPHENYLACETALDEHYDE//3 4 DIHYDROXYPHENYLGLYCOLALDEHYDE//DOPAL

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
29898 178 47.8 76%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
11 4 NEUROSCIENCES//CLINICAL NEUROLOGY//NEUROL 1112395
124 3       PARKINSONS DISEASE//MOVEMENT DISORDERS//DEEP BRAIN STIMULATION 67777
332 2             PARKINSONS DISEASE//ALPHA SYNUCLEIN//PARKIN 18089
29898 1                   3 4 DIHYDROXYPHENYLACETALDEHYDE//3 4 DIHYDROXYPHENYLGLYCOLALDEHYDE//DOPAL 178

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 3 4 DIHYDROXYPHENYLACETALDEHYDE authKW 1297322 6% 69% 11
2 3 4 DIHYDROXYPHENYLGLYCOLALDEHYDE authKW 1200833 4% 100% 7
3 DOPAL authKW 914915 4% 67% 8
4 DIHYDROXYPHENYLACETALDEHYDE authKW 686190 2% 100% 4
5 EXON MICROARRAYS authKW 385981 2% 75% 3
6 SKP1A authKW 343095 1% 100% 2
7 DIRNIH address 308777 3% 30% 6
8 CLIN NEUROCARDIOL SECT address 269780 10% 9% 18
9 3 4 DIDHYDROXYPHENYLGLYCOLALDEHYDE authKW 171548 1% 100% 1
10 3 4 DIHYDROXYPHENYLACETALDEHYDE DOPAL authKW 171548 1% 100% 1

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 Neurosciences 1351 51% 0% 90
2 Clinical Neurology 767 29% 0% 52
3 Toxicology 72 7% 0% 12
4 Pathology 55 6% 0% 10
5 Biochemistry & Molecular Biology 50 18% 0% 32
6 Chemistry, Medicinal 49 6% 0% 10
7 Pharmacology & Pharmacy 30 10% 0% 18
8 Multidisciplinary Sciences 25 2% 0% 4
9 Genetics & Heredity 23 6% 0% 11
10 Psychiatry 21 5% 0% 9

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 DIRNIH 308777 3% 30% 6
2 CLIN NEUROCARDIOL SECT 269780 10% 9% 18
3 ANAT CELL BIOL PSYCHIAT 171548 1% 100% 1
4 BIOINFORMAT CORE SYN T NEUROBIOL 171548 1% 100% 1
5 BIOL SCI INSB 171548 1% 100% 1
6 CLIN NEUROL MOVEMENT DISORDERS UNIT 171548 1% 100% 1
7 CLIN NEUROSCI PROGRAM INTRAMURAL 171548 1% 100% 1
8 EDMOND LILLY SAFRA BRAIN SCI 171548 1% 100% 1
9 EFE TOPF EXCELLENCE 171548 1% 100% 1
10 EVE TOPF PARKINSON FDN NEURODEGENERAT 171548 1% 100% 1

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 NEURODEGENERATIVE DISEASES 3982 2% 1% 4
2 NEUROGENETICS 2550 2% 0% 3
3 NEUROBIOLOGY OF DISEASE 2290 4% 0% 7
4 BIOORGANIC CHEMISTRY 1858 2% 0% 4
5 PARKINSONISM & RELATED DISORDERS 1786 3% 0% 5
6 PARKINSONS DISEASE 1642 1% 0% 2
7 ZHURNAL NEVROPATOLOGII I PSIKHIATRII IMENI S S KORSAKOVA 1268 3% 0% 5
8 MOLECULAR NEURODEGENERATION 1226 1% 0% 2
9 CHEMICAL RESEARCH IN TOXICOLOGY 1180 3% 0% 6
10 NEURODEGENERATION 1031 1% 1% 1

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 3 4 DIHYDROXYPHENYLACETALDEHYDE 1297322 6% 69% 11 Search 3+4+DIHYDROXYPHENYLACETALDEHYDE Search 3+4+DIHYDROXYPHENYLACETALDEHYDE
2 3 4 DIHYDROXYPHENYLGLYCOLALDEHYDE 1200833 4% 100% 7 Search 3+4+DIHYDROXYPHENYLGLYCOLALDEHYDE Search 3+4+DIHYDROXYPHENYLGLYCOLALDEHYDE
3 DOPAL 914915 4% 67% 8 Search DOPAL Search DOPAL
4 DIHYDROXYPHENYLACETALDEHYDE 686190 2% 100% 4 Search DIHYDROXYPHENYLACETALDEHYDE Search DIHYDROXYPHENYLACETALDEHYDE
5 EXON MICROARRAYS 385981 2% 75% 3 Search EXON+MICROARRAYS Search EXON+MICROARRAYS
6 SKP1A 343095 1% 100% 2 Search SKP1A Search SKP1A
7 3 4 DIDHYDROXYPHENYLGLYCOLALDEHYDE 171548 1% 100% 1 Search 3+4+DIDHYDROXYPHENYLGLYCOLALDEHYDE Search 3+4+DIDHYDROXYPHENYLGLYCOLALDEHYDE
8 3 4 DIHYDROXYPHENYLACETALDEHYDE DOPAL 171548 1% 100% 1 Search 3+4+DIHYDROXYPHENYLACETALDEHYDE+DOPAL Search 3+4+DIHYDROXYPHENYLACETALDEHYDE+DOPAL
9 4 DIHYDROXYPHENYL ACETALDEHYDE 171548 1% 100% 1 Search 4+DIHYDROXYPHENYL+ACETALDEHYDE Search 4+DIHYDROXYPHENYL+ACETALDEHYDE
10 5 HYDROXYINDOLEALDEHYDE 171548 1% 100% 1 Search 5+HYDROXYINDOLEALDEHYDE Search 5+HYDROXYINDOLEALDEHYDE

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref.
in cl.		 Shr. of ref. in
cl.		 Citations
1 ANDERSON, DG , FLORANG, VR , SCHAMP, JH , BUETTNER, GR , DOORN, JA , (2016) ANTIOXIDANT-MEDIATED MODULATION OF PROTEIN REACTIVITY FOR 3,4-DIHYDROXYPHENYLACETALDEHYDE, A TOXIC DOPAMINE METABOLITE.CHEMICAL RESEARCH IN TOXICOLOGY. VOL. 29. ISSUE 7. P. 1098 -1107 18 46% 0
2 GOLDSTEIN, DS , SULLIVAN, P , HOLMES, C , KOPIN, IJ , BASILE, MJ , MASH, DC , (2011) CATECHOLS IN POST-MORTEM BRAIN OF PATIENTS WITH PARKINSON DISEASE.EUROPEAN JOURNAL OF NEUROLOGY. VOL. 18. ISSUE 5. P. 703 -710 12 67% 44
3 CASIDA, JE , FORD, B , JINSMAA, Y , SULLIVAN, P , COONEY, A , GOLDSTEIN, DS , (2014) BENOMYL, ALDEHYDE DEHYDROGENASE, DOPAL, AND THE CATECHOLALDEHYDE HYPOTHESIS FOR THE PATHOGENESIS OF PARKINSON'S DISEASE.CHEMICAL RESEARCH IN TOXICOLOGY. VOL. 27. ISSUE 8. P. 1359 -1361 13 59% 5
4 GOLDSTEIN, DS , SULLIVAN, P , HOLMES, C , MILLER, GW , ALTER, S , STRONG, R , MASH, DC , KOPIN, IJ , SHARABI, Y , (2013) DETERMINANTS OF BUILDUP OF THE TOXIC DOPAMINE METABOLITE DOPAL IN PARKINSON'S DISEASE.JOURNAL OF NEUROCHEMISTRY. VOL. 126. ISSUE 5. P. 591 -603 18 38% 19
5 GOLDSTEIN, DS , SULLIVAN, P , COONEY, A , JINSMAA, Y , KOPIN, IJ , SHARABI, Y , (2015) ROTENONE DECREASES INTRACELLULAR ALDEHYDE DEHYDROGENASE ACTIVITY: IMPLICATIONS FOR THE PATHOGENESIS OF PARKINSON'S DISEASE.JOURNAL OF NEUROCHEMISTRY. VOL. 133. ISSUE 1. P. 14 -25 15 44% 2
6 GOLDSTEIN, DS , HOLMES, C , SULLIVAN, P , JINSMAA, Y , KOPIN, IJ , SHARABI, Y , (2016) ELEVATED CEREBROSPINAL FLUID RATIOS OF CYSTEINYL-DOPAMINE/3,4-DIHYDROXYPHENYLACETIC ACID IN PARKINSONIAN SYNUCLEINOPATHIES.PARKINSONISM & RELATED DISORDERS. VOL. 31. ISSUE . P. 79 -86 18 36% 0
7 GRUNBLATT, E , RIEDERER, P , (2016) ALDEHYDE DEHYDROGENASE (ALDH) IN ALZHEIMER'S AND PARKINSON'S DISEASE.JOURNAL OF NEURAL TRANSMISSION. VOL. 123. ISSUE 2. P. 83 -90 16 33% 1
8 ALIEVA, AK , FILATOVA, EV , KARABANOV, AV , ILLARIOSHKIN, SN , SLOMINSKY, PA , SHADRINA, MI , (2015) POTENTIAL BIOMARKERS OF THE EARLIEST CLINICAL STAGES OF PARKINSON'S DISEASE.PARKINSONS DISEASE. VOL. . ISSUE . P. - 14 40% 0
9 GOLDSTEIN, DS , KOPIN, IJ , SHARABI, Y , (2014) CATECHOLAMINE AUTOTOXICITY. IMPLICATIONS FOR PHARMACOLOGY AND THERAPEUTICS OF PARKINSON DISEASE AND RELATED DISORDERS.PHARMACOLOGY & THERAPEUTICS. VOL. 144. ISSUE 3. P. 268 -282 33 16% 4
10 HOLMES, C , WHITTAKER, N , HEREDIA-MOYA, J , GOLDSTEIN, DS , (2010) CONTAMINATION OF THE NOREPINEPHRINE PRODRUG DROXIDOPA BY DIHYDROXYPHENYLACETALDEHYDE.CLINICAL CHEMISTRY. VOL. 56. ISSUE 5. P. 832-838 8 73% 3

Classes with closest relation at Level 1


Rank Class id link
1 31950 CLINICAL DEMENTIA//MENTAL IMPAIRMENTS NEUROL DISORDERS MIND//PHARMACONEUROIMMUNOL PROGRAM
2 24398 ROTENONE//AAV ALPHA SYNUCLEIN//PYRIMIDOTRIAZINEDIONE DERIVATIVES
3 6773 LRRK2//LEUCINE RICH REPEAT KINASE 2//LEUCINE RICH REPEAT KINASE 2 LRRK2
4 10607 PARKINSONS DISEASE//CARDIAC SYMPATHETIC DENERVATION//U913
5 477 ALPHA SYNUCLEIN//SYNUCLEIN//LEWY BODY
6 7381 NEUROMELANIN//AMINOCHROME//DOPAMINE QUINONE
7 4921 PARKINSONS DISEASE//MANEB//MOL CELLULAR TOXICOL HUMAN PLICAT
8 20679 BRAIN BANK//BRAIN DONATION//AGONAL STATE
9 25950 SKIN BARRIER NETWORK HUMAN OURCES DEV TEAM BK2//LEWY BODY INCLUSION//3 4 5 TRICAFFEOYLQUINIC ACID
10 8954 NEUROPHARMACOL SECT//MICROGLIA//PARKINSONS DISEASE

Go to start page